Immediate Impact

56 by Nobel laureates 44 from Science/Nature 85 standout
Sub-graph 1 of 18

Citing Papers

The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia
2021 StandoutNature
52 intermediate papers

Works of Tilo Schwientek being referenced

Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance
2005
O‐Linked glycans control glycoprotein processing by antigen‐presenting cells: a biochemical approach to the molecular aspects of MUC1 processing by dendritic cells
2003
and 12 more

Author Peers

Author Last Decade Papers Cites
Tilo Schwientek 1925 779 763 33 2.2k
Alison V. Nairn 2081 629 668 33 2.5k
Yoshiki Narimatsu 2150 601 746 60 2.6k
Katrine T. Schjoldager 1962 584 663 34 2.3k
Adnan Halim 2317 588 522 47 2.8k
Marie‐Ange Krzewinski‐Recchi 1561 404 633 39 1.9k
Raj Parekh 1718 495 393 29 2.2k
Stephan Hinderlich 2520 792 511 80 3.0k
Helle Hassan 1621 795 695 23 1.8k
Timothy A. Fritz 1522 642 462 21 1.8k
Nobuyuki Kurosawa 1916 380 606 76 2.3k

All Works

Loading papers...

Rankless by CCL
2026